Pre-market hot trades in US stocks: Psyence Biomedical pre-market down 12.09%; XORTX Therapeutics pre-market down 11.23%

Pre-market Hot Trades in US Stocks Psyence Biomedical is down 12.09% in pre-market trading. Based on recent news, On April 22, technical analysis of Psyence Biomedical showed that although the stock price rebounded from the February low, it remains well below the 52-week high. The Relative Strength Index (RSI) is at 96.18, indicating that the stock may be overbought. The stock price has fallen 43.93% over the past 12 months, and the overall trend remains weak. On April 20, Psyence Biomedical was positioned as the world's only supplier of pharmaceutical-grade ibogaine, which has attracted market attention and discussion. On April 19, the U.S. President signed an executive order to accelerate research and approval processes for psychedelic therapies, focusing on drugs like ibogaine for treating post-traumatic stress disorder, depression, and addiction. Industry trends indicate an acceleration in psychedelic therapy research. XORTX is down 11.23% in pre-market trading. Based on recent key news: On April 21, XORTX Therapeutics announced that it has received a compliance letter from Nasdaq confirming that the company has met the minimum bid requirement. The company achieved compliance through a 1-for-5 reverse stock split, with the stock price trading above $1 for 10 consecutive days, addressing the shortfall in the minimum bid requirement. This news had a positive impact on the stock price but did not prevent the pre-market decline. On April 21, technical sentiment signals indicated a strong sell, and the market holds a pessimistic view on XORTX's stock. Despite the company's market capitalization of CAD 4.16 million, trading volume and market sentiment reflect a cautious attitude from investors. On April 21, XORTX's product line includes XRx-101 for acute kidney injury and respiratory viral infections, as well as early candidates for diabetic nephropathy and other rare kidney diseases. Despite a rich product line, the market remains cautious about its future performance. Market sentiment is pessimistic, and trading volume shows a cautious attitude. Top Gainers in Pre-market US Stocks Huachen AI Parking Management Tech is up 76.58% in pre-market trading, with no significant recent news. Trading is active, and capital flows are evident. Considering sector and industry trends, the stock shows significant volatility, and the specific reasons need further observation. eLong Power is up 45.86% in pre-market trading. Based on recent key news: On April 20, eLong Power announced a major business expansion plan in an announcement released through the EDGAR system. This plan involves strategic cooperation with several international companies and is expected to significantly enhance the company's future profitability, driving the stock price up sharply by 45.86% in pre-market trading. Source: EDGAR announcement. On April 19, the market showed strong interest in eLong Power's new energy projects. The company's innovative technologies in the new energy sector have gained industry recognition, attracting significant investor attention and further driving up the stock price Source: Zhitong Finance On April 18, analysts upgraded eLong Power's rating, expecting its earnings in the coming quarters to exceed market expectations. Analysts believe that the company's advantages in technology research and development and market expansion will lead to sustained growth, enhancing investor confidence. Source: Morgan Stanley analyst report indicates strong performance in the new energy sector, with significant capital inflows. ALPHA COMPUTE CORPORATION, pre-market up 39.36%, with no significant news recently. Trading is active, and capital flow is evident. Considering the sector and industry trends, the stock shows significant volatility, and the specific reasons need further observation